Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2



Rating:

Share or cite this content

Citations should be made in the following way:
S. Birring (London, United Kingdom), J. Smith (Manchester, United Kingdom), A. Morice (Cottingham, United Kingdom), I. Pavord (Oxford, United Kingdom), P. Dicpinigaitis (Bronx, United States of America), L. Mcgarvey (Belfast, United Kingdom), A. Tzontcheva (Kenilworth, United States of America), Q. Li (Kenilworth, United States of America), A. Martin Nguyen (Kenilworth, United States of America), J. Schelfhout (Kenilworth, United States of America), D. Muccino (Kenilworth, United States of America), C. La Rosa (Kenilworth, United States of America). The Cough Severity Diary in a pooled analysis of two, phase 3 trials of gefapixant in chronic cough. 4060

Member's Comments

No comment yet.

Related content which might interest you: The Leicester Cough Questionnaire in two phase 3 trials of gefapixant in chronic cough Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Patient-reported chronic cough severity over 52 weeks in two phase 3 trials of gefapixant Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Use of the acute bronchitis symptom severity (ABSS) scale across language versions in the MOSAIC trial Source: Eur Respir J 2003; 22: Suppl. 45, 67s Year: 2003 Validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough Source: Eur Respir J 2008; 31: 1013-1018 Year: 2008 Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials Source: International Congress 2016 – Asthma management Year: 2016 Levodropropizine effect on respiratory centre output, a randomized clinical trial Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Improvements in cough severity and cough-related quality of life in a phase 2 trial (RELIEF) with the P2X3 antagonist BLU-5937 in refractory chronic cough (RCC) Source: Virtual Congress 2021 – Clinical trials in airway diseases: novel treatments and new evidence Year: 2021 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 Chronic cough: objective cough frequency in a large cough clinic cohort Source: International Congress 2017 – Notable abstracts in asthma Year: 2017 Validation of the COPD symptoms diary (CSD) Source: Eur Respir J 2004; 24: Suppl. 48, 142s Year: 2004 Translation, validity and reliability of the Leicester cough questionnaire into Swedish in COPD Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient Year: 2016 Relationship between exacerbation frequency and quality of life using the airways questionnaire 20 (AQ20) in a randomised controlled trial Source: Eur Respir J 2005; 26: Suppl. 49, 715s Year: 2005 Symptom variability in patients with severe COPD: a pan-European cross-sectional study Source: Eur Respir J 2011; 37: 264 Year: 2011 Changes in COPD symptom control questionnaire (CCQ) scores after seven days of treatment with prednisolone of acute exacerbations in hospitalised patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 54s Year: 2003 Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 Evaluating symptom outcomes in patients with COPD: reliability and validity of the breathlessness, cough and sputum scale Source: Eur Respir J 2001; 18: Suppl. 33, 461s Year: 2001 Symptom management: dyspnoea and cough Source: Eur Respir Monogr 2016; 71: 218-229 Year: 2016